PortfoliosLab logoPortfoliosLab logo
CADL vs. GMEX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CADL vs. GMEX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Candel Therapeutics, Inc. (CADL) and GMEX Robotics Corporation (GMEX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


CADL

1D
10.11%
1M
14.52%
YTD
61.95%
6M
54.04%
1Y
92.63%
3Y*
86.97%
5Y*
10Y*

GMEX

1D
0.11%
1M
-62.31%
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CADL vs. GMEX - Yearly Performance Comparison


Correlation

The correlation between CADL and GMEX is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (All Time)
Calculated using the full available price history since Mar 11, 2026

0.09

Fundamentals

Market Cap

CADL:

$570.61M

GMEX:

$418.10K

EPS

CADL:

-$0.97

GMEX:

-$36.49

PB Ratio

CADL:

4.13

GMEX:

0.05

Total Revenue (TTM)

CADL:

$0.00

GMEX:

$7.50M

Gross Profit (TTM)

CADL:

-$600.00K

GMEX:

$552.69K

EBITDA (TTM)

CADL:

-$71.64M

GMEX:

-$8.85M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CADL vs. GMEX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CADL
CADL Risk / Return Rank: 7777
Overall Rank
CADL Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
CADL Sortino Ratio Rank: 7777
Sortino Ratio Rank
CADL Omega Ratio Rank: 7474
Omega Ratio Rank
CADL Calmar Ratio Rank: 8080
Calmar Ratio Rank
CADL Martin Ratio Rank: 7474
Martin Ratio Rank

GMEX

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CADL vs. GMEX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Candel Therapeutics, Inc. (CADL) and GMEX Robotics Corporation (GMEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CADLGMEXDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.25

Calmar ratioReturn relative to maximum drawdown

2.51

Martin ratioReturn relative to average drawdown

4.52

CADL vs. GMEX - Sharpe Ratio Comparison


Loading charts...

Drawdowns

CADL vs. GMEX - Drawdown Comparison

The maximum CADL drawdown since its inception was -94.33%, roughly equal to the maximum GMEX drawdown of -94.62%. Use the drawdown chart below to compare losses from any high point for CADL and GMEX.


Loading charts...

Drawdown Indicators


CADLGMEXDifference

Max Drawdown

Largest peak-to-trough decline

-94.33%

-94.62%

+0.29%

Max Drawdown (1Y)

Largest decline over 1 year

-37.04%

Max Drawdown (3Y)

Largest decline over 3 years

-72.86%

Current Drawdown

Current decline from peak

-34.64%

-94.62%

+59.98%

Average Drawdown

Average peak-to-trough decline

-62.57%

-76.64%

+14.07%

Ulcer Index

Depth and duration of drawdowns from previous peaks

20.57%

Volatility

CADL vs. GMEX - Volatility Comparison


Loading charts...

Volatility by Period


CADLGMEXDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.78%

Volatility (6M)

Calculated over the trailing 6-month period

52.74%

Volatility (1Y)

Calculated over the trailing 1-year period

73.67%

183.11%

-109.44%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

166.61%

183.11%

-16.50%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

166.61%

183.11%

-16.50%

Dividends

CADL vs. GMEX - Dividend Comparison

Neither CADL nor GMEX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CADL vs. GMEX - Financials Comparison

This section allows you to compare key financial metrics between Candel Therapeutics, Inc. and GMEX Robotics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00M2.00M3.00M4.00M5.00M202220232024202520260
1.79M
(CADL) Total Revenue
(GMEX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CADL and GMEX have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for CADL and GMEX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer